- Home
- GILT vs MRVI Comparison
GILT vs MRVI Comparison
Compare GILT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILT
- MRVI
- Stock Information
- Founded
- GILT 1987
- MRVI 2014
- Country
- GILT Israel
- MRVI United States
- Employees
- GILT N/A
- MRVI N/A
- Industry
- GILT Radio And Television Broadcasting And Communications Equipment
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- GILT Technology
- MRVI Health Care
- Exchange
- GILT Nasdaq
- MRVI Nasdaq
- Market Cap
- GILT 381.2M
- MRVI 312.4M
- IPO Year
- GILT 1993
- MRVI 2020
- Fundamental
- Price
- GILT $7.38
- MRVI $2.76
- Analyst Decision
- GILT Strong Buy
- MRVI Hold
- Analyst Count
- GILT 2
- MRVI 10
- Target Price
- GILT $8.50
- MRVI $6.84
- AVG Volume (30 Days)
- GILT 474.5K
- MRVI 2.0M
- Earning Date
- GILT 08-06-2025
- MRVI 08-06-2025
- Dividend Yield
- GILT N/A
- MRVI N/A
- EPS Growth
- GILT N/A
- MRVI N/A
- EPS
- GILT 0.24
- MRVI N/A
- Revenue
- GILT $321,407,000.00
- MRVI $241,856,000.00
- Revenue This Year
- GILT $42.88
- MRVI N/A
- Revenue Next Year
- GILT $13.26
- MRVI $10.62
- P/E Ratio
- GILT $31.38
- MRVI N/A
- Revenue Growth
- GILT 13.49
- MRVI N/A
- 52 Week Low
- GILT $4.04
- MRVI $1.67
- 52 Week High
- GILT $8.07
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- GILT 63.94
- MRVI 71.44
- Support Level
- GILT $7.01
- MRVI $2.52
- Resistance Level
- GILT $8.07
- MRVI $2.72
- Average True Range (ATR)
- GILT 0.27
- MRVI 0.18
- MACD
- GILT 0.05
- MRVI 0.06
- Stochastic Oscillator
- GILT 58.61
- MRVI 95.65
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.